Qing Shao

Dr. Qing Shao


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in Development
Verified
Journal Article
Open access
PDF file
AFAnn Marie Flenniken
Ann Marie Flenniken
LOLucy Osborne
Lucy Osborne
NANicole Anderson
Nicole Anderson
NCNadia Ciliberti
Nadia Ciliberti
CFCraig Fleming
Craig Fleming
JRJanet Rossant
Janet Rossant
Oculodentodigital dysplasia (ODDD) is an autosomal dominant disorder characterized by pleiotropic developmental anomalies of the limbs, teeth, face and eyes that was shown recently to be caused by mutations in the gap junction protein alpha 1 gene (GJA1), encoding connexin 43 (Cx43). In the course of performing an N-ethyl-N-nitrosourea mutagenesis screen, we identified a dominant mouse mutation that exhibits many classic symptoms of ODDD, including syndactyly, enamel hypoplasia, craniofacial anomalies and cardiac dysfunction. Positional cloning revealed that these mice carry a point mutation in Gja1 leading to the substitution of a highly conserved amino acid (G60S) in Cx43. In vivo and in vitro studies revealed that the mutant Cx43 protein acts in a dominant-negative fashion to disrupt gap junction assembly and function. In addition to the classic features of ODDD, these mutant mice also showed decreased bone mass and mechanical strength, as well as altered hematopoietic stem cell and progenitor populations. Thus, these mice represent an experimental model with which to explore the clinical manifestations of ODDD and to evaluate potential intervention strategies.

30 June 2020 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
NXNan Xu
Nan Xu
YSYao Shi
Yao Shi
YHYi He
Yi He
QSQing Shao
Qing Shao

11 August 2022 in Cancer Research
Verified
Journal Article
Closed access
PDF file
ZZZhuangzhuang Zhang
Zhuangzhuang Zhang
LCLijun Cheng
Lijun Cheng
JLJie Li
Jie Li
QQQi Qiao
Qi Qiao
AKAnju Karki
Anju Karki
XLXiaoqi Liu
Xiaoqi Liu
Polo-like kinase 1 (Plk1) plays an important role in cell-cycle regulation. Recent work has suggested that Plk1 could be a biomarker of gemcitabine response in pancreatic ductal adenocarcinoma (PDAC). Although targeting Plk1 to treat PDAC has been attempted in clinical trials, the results were not promising, and the mechanisms of resistance to Plk1 inhibition is poorly understood. In addition, the role of Plk1 in PDAC progression requires further elucidation. Here, we showed that Plk1 was associated with poor outcomes in patients with PDAC. In an inducible transgenic mouse line with specific expression of Plk1 in the pancreas, Plk1 overexpression significantly inhibited caerulein-induced acute pancreatitis and delayed development of acinar-to-ductal metaplasia and pancreatic intraepithelial neoplasia. Bioinformatics analyses identified the regulatory networks in which Plk1 is involved in PDAC disease progression, including multiple inflammation-related pathways. Unexpectedly, inhibition or depletion of Plk1 resulted in upregulation of PD-L1 via activation of the NF-κB pathway. Mechanistically, Plk1-mediated phosphorylation of RB at S758 inhibited the translocation of NF-κB to nucleus, inactivating the pathway. Inhibition of Plk1 sensitized PDAC to immune checkpoint blockade therapy through activation of an antitumor immune response. Together, Plk1 suppresses PDAC progression and inhibits NF-κB activity, and targeting Plk1 can potentiate the efficacy of immunotherapy in PDAC. Significance: Inhibition of Plk1 induces upregulation of PD-L1 expression in pancreatic ductal adenocarcinoma, stimulating antitumor immunity and sensitizing tumors to immunotherapy.

28 July 2021 in AIChE Journal
Verified
Journal Article
Closed access
PDF file
UAUsman L. Abbas
Usman L. Abbas
QQQi Qiao
Qi Qiao
MNManh Tien Nguyen
Manh Tien Nguyen
Jian ShiJian Shi
Jian Shi
QSQing Shao
Qing Shao

29 April 2021 in Molecular Systems Design & Engineering
Verified
Journal Article
Closed access
PDF file
XCXumin Chen
Xumin Chen
CLChen Li
Chen Li
MBMatthew Bernards
Matthew Bernards
YSYao Shi
Yao Shi
QSQing Shao
Qing Shao
YHYi He
Yi He
This article reviews recent work that uses deep learning algorithms to identify and generate functional peptides as well as predict their biological properties.

12 December 2024 in Advanced Science
Verified
Journal Article
Open access
DWDuolin Wang
Duolin Wang
MPMahdi Pourmirzaei
Mahdi Pourmirzaei
UAUsman L. Abbas
Usman L. Abbas
SZShuai Zeng
Shuai Zeng
NMNegin Manshour
Negin Manshour
DXDong Xu
Dong Xu
Proteins play an essential role in various biological and engineering processes. Large protein language models (PLMs) present excellent potential to reshape protein research by accelerating the determination of protein functions and the design of proteins with the desired functions. The prediction and design capacity of PLMs relies on the representation gained from the protein sequences. However, the lack of crucial 3D structure information in most PLMs restricts the prediction capacity of PLMs in various applications, especially those heavily dependent on 3D structures. To address this issue, S‐PLM is introduced as a 3D structure‐aware PLM that utilizes multi‐view contrastive learning to align the sequence and 3D structure of a protein in a coordinated latent space. S‐PLM applies Swin‐Transformer on AlphaFold‐predicted protein structures to embed the structural information and fuses it into sequence‐based embedding from ESM2. Additionally, a library of lightweight tuning tools is provided to adapt S‐PLM for diverse downstream protein prediction tasks. The results demonstrate S‐PLM's superior performance over sequence‐only PLMs on all protein clustering and classification tasks, achieving competitiveness comparable to state‐of‐the‐art methods requiring both sequence and structure inputs. S‐PLM and its lightweight tuning tools are available at https://github.com/duolinwang/S-PLM/.